ArticlePharmaceutical science advances2026
Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD.
Xiaobing Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.